OpenAlex
PricingAboutJobs
Log inGet started
Work

Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure

HTML

Year: 2004
Type: article
Study design: Study Protocol
Source: Expert Opinion on Investigational Drugs
DOI: 10.1517/13543784.13.11.1509
Authors: Ronald S Freudenberger, Richard P Schwarz Jr, Joanne Brown, Alan Moore, Douglas Mann, Michael M Givertz, Wilson S Colucci, Joshua M Hare
Institutions: University of Medicine and Dentistry of New Jersey, Baylor College of Medicine, Brigham and Women's Hospital, Boston University, Johns Hopkins University
Language: English

Topic: Heart Failure Treatment and Management
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: oxypurinol, xanthine oxidase inhibitors, congestive heart failure, NYHA class III-IV heart failure, endothelial dysfunction, myocardial energy metabolism, oxidative stress, uric acid, inotropic effect, drug safety and efficacy, placebo-controlled trial design
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2164427101
FWCI: 6.451
Cites: 25
Cited by: 60
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security